Novartis and Pear to collaborate on prescription software applications for schizophrenia and MS March 1, 2018 No Comments
Researchers discover OAT-2068, a highly selective and orally bioavailable inhibitor of mCHIT1 Feb. 22, 2018 No Comments
RSS